UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Azathioprine and 6-mercaptopurine pharmacogenetics and metabolite monitoring in inflammatory bowel disease

Journal of gastroenterology and hepatology, 2005-08, Vol.20 (8), p.1149-1157

2005

Volltextzugriff (PDF)

Efficacy of the low FODMAP diet for treating irritable bowel syndrome: the evidence to date

Clinical and Experimental Gastroenterology, 2016-01, Vol.9 (Issue 1), p.131-142

2016

Volltextzugriff (PDF)

Gastrointestinal: Hepatic abscess after botulinum toxin type—A therapy for achalasia

Journal of gastroenterology and hepatology, 2017-10, Vol.32 (10), p.1663-1663

2017

Volltextzugriff (PDF)

Gastrointestinal: Ulcerative colitis‐associated duodenitis

Journal of gastroenterology and hepatology, 2018-05, Vol.33 (5), p.973-973

2018

Volltextzugriff (PDF)

Review article: appropriate use of corticosteroids in Crohn’s disease

Alimentary pharmacology & therapeutics, 2007-08, Vol.26 (3), p.313-329

2007

Volltextzugriff (PDF)

Fructose malabsorption in people with and without gout: A case–control study

Seminars in arthritis and rheumatism, 2017-10, Vol.47 (2), p.257-263

2017

Volltextzugriff (PDF)

Hospital Admissions and Costs of Crohn's Disease in New Zealand and the Impact of Adalimumab

Value in health, 2016-11, Vol.19 (7), p.A837-A837

2016

Volltextzugriff (PDF)

PGI3 - Hospital Admissions and Costs of Crohn's Disease in New Zealand and the Impact of Adalimumab

Value in health, 2016-11, Vol.19 (7), p.A837-A837

2016

Volltextzugriff (PDF)

Exposure to thiopurine drugs through breast milk is low based on metabolite concentrations in mother‐infant pairs

British journal of clinical pharmacology, 2006-10, Vol.62 (4), p.453-456

2006

Volltextzugriff (PDF)

Azathioprine and allopurinol: A two-edged interaction

Journal of gastroenterology and hepatology, 2010-04, Vol.25 (4), p.653-655

2010

Volltextzugriff (PDF)

Thiopurine drug adverse effects in a population of New Zealand patients with inflammatory bowel disease

Pharmacoepidemiology and drug safety, 2004-08, Vol.13 (8), p.563-567

2004

Volltextzugriff (PDF)

Difficulties and possibilities with thiopurine therapy in inflammatory bowel disease—Proceedings of the first Thiopurine Task Force meeting

Digestive and liver disease, 2011-04, Vol.43 (4), p.270-276

2011

Volltextzugriff (PDF)

Thiopurine S‐methyltransferase (TPMT) genotype does not predict adverse drug reactions to thiopurine drugs in patients with inflammatory bowel disease

Alimentary pharmacology & therapeutics, 2003-08, Vol.18 (4), p.395-400

2003

Volltextzugriff (PDF)

Thiopurine hepatotoxicity in inflammatory bowel disease: the role for adding allopurinol

Expert opinion on drug safety, 2008-09, Vol.7 (5), p.607-616

2008

Volltextzugriff (PDF)

Thiopurine methyltransferase and 6-thioguanine nucleotide measurement: early experience of use in clinical practice

Internal medicine journal, 2005-10, Vol.35 (10), p.580-585

2005

Volltextzugriff (PDF)

Caspase Recruitment Domain-Containing protein 15 mutations in patients with colorectal cancer

Cancer research (Chicago, Ill.), 2006-03, Vol.66 (5), p.2532-2535

2006

Volltextzugriff (PDF)

Surveillance for Dysplasia in Patients With Inflammatory Bowel Disease: A National Survey of Colonoscopic Practice in New Zealand

Diseases of the colon & rectum, 2004-03, Vol.47 (3), p.314-322

2004

Volltextzugriff (PDF)

A multiplexed allele-specific polymerase chain reaction assay for the detection of common thiopurine S-methyltransferase (TPMT) mutations

Clinica chimica acta, 2004-03, Vol.341 (1), p.49-53

2004

Volltextzugriff (PDF)

CARD15 allele frequency differences in New Zealand Maori: ancestry specific susceptibility to Crohn’s disease in New Zealand?

Gut, 2006-04, Vol.55 (4), p.580-580

2006

Volltextzugriff (PDF)

Gastrointestinal: Mycobacterium avium paratuberculosis and Crohn's disease

Journal of gastroenterology and hepatology, 2005-12, Vol.20 (12), p.1943-1943

2005

Volltextzugriff (PDF)

A systematic review of case-control studies assessing environmental factors associated with inflammatory bowel disease (IBD)

JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2006, Vol.21, p.A261

2006

Volltextzugriff (PDF)

Spontaneous calcific cerebral embolus

Australasian radiology, 2005-04, Vol.49 (2), p.154-156

2005

Volltextzugriff (PDF)

Lack of association between the ITPA 94C>A polymorphism and adverse effects from azathioprine

Pharmacogenetics (London), 2004-11, Vol.14 (11), p.779-781

2004

Volltextzugriff (PDF)

Spontaneous calcific cerebral embolus

Australasian Radiology, 2005, Vol.49 (2), p.154-156

2005

Volltextzugriff (PDF)

A Prospective Evaluation of S100A12 in IBD Patients in the Novel Biomarkers in Inflammatory Bowel Disease (NBIBD) Project

Annals of Paediatric Rheumatology, 2012, Vol.1, p.1

2012

Volltextzugriff (PDF)

1 – 25 von 26

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(21)
Mit Volltextzugriff
(23)

Publikationsform

Sprache

Englisch
(26)

Erscheinungsjahr

n.n

Menü

Weitere Dienste

Einstellungen

Azathioprine and 6-mercaptopurine pharmacogenetics and metabolite monitoring in inflammatory bowel disease

Efficacy of the low FODMAP diet for treating irritable bowel syndrome: the evidence to date

Gastrointestinal: Hepatic abscess after botulinum toxin type—A therapy for achalasia

Gastrointestinal: Ulcerative colitis‐associated duodenitis

Review article: appropriate use of corticosteroids in Crohn’s disease

Fructose malabsorption in people with and without gout: A case–control study

Hospital Admissions and Costs of Crohn's Disease in New Zealand and the Impact of Adalimumab

PGI3 - Hospital Admissions and Costs of Crohn's Disease in New Zealand and the Impact of Adalimumab

Exposure to thiopurine drugs through breast milk is low based on metabolite concentrations in mother‐infant pairs

Azathioprine and allopurinol: A two-edged interaction

Thiopurine drug adverse effects in a population of New Zealand patients with inflammatory bowel disease

Difficulties and possibilities with thiopurine therapy in inflammatory bowel disease—Proceedings of the first Thiopurine Task Force meeting

Thiopurine S‐methyltransferase (TPMT) genotype does not predict adverse drug reactions to thiopurine drugs in patients with inflammatory bowel disease

Thiopurine hepatotoxicity in inflammatory bowel disease: the role for adding allopurinol

Thiopurine methyltransferase and 6-thioguanine nucleotide measurement: early experience of use in clinical practice

Caspase Recruitment Domain-Containing protein 15 mutations in patients with colorectal cancer

Surveillance for Dysplasia in Patients With Inflammatory Bowel Disease: A National Survey of Colonoscopic Practice in New Zealand

A multiplexed allele-specific polymerase chain reaction assay for the detection of common thiopurine S-methyltransferase (TPMT) mutations

CARD15 allele frequency differences in New Zealand Maori: ancestry specific susceptibility to Crohn’s disease in New Zealand?

Gastrointestinal: Mycobacterium avium paratuberculosis and Crohn's disease

A systematic review of case-control studies assessing environmental factors associated with inflammatory bowel disease (IBD)

Spontaneous calcific cerebral embolus

Lack of association between the ITPA 94C>A polymorphism and adverse effects from azathioprine

Spontaneous calcific cerebral embolus

A Prospective Evaluation of S100A12 in IBD Patients in the Novel Biomarkers in Inflammatory Bowel Disease (NBIBD) Project

Suchergebnisse filtern